Stoke Therapeutics, Inc. (STOK) Earnings Call Analysis
NASDAQ · Unknown · Unknown
Next earnings call: 2026-08-03
(Q2 2026)
— full calendar
Earnings Reports
-
Stoke Therapeutics (STOK) Q1 2026: EMPEROR Phase 3 Nears 150-Patient Enrollment, Four-Year OLE Data Deepens Label Leverage
May 08, 2026
-
Stoke Therapeutics (STOK) Q3 2025: R&D Spend Jumps 70% as Phase III Enrollment Surges Past 200 Patients
November 05, 2025
-
Stoke Therapeutics (STOK) Q2 2025: 36-Month Cognition Gains Anchor Zareva-Nursen’s Disease-Modifying Case
August 12, 2025